TABLE 3.
CPS Mutation | growth rate (h) | transient efficiency (% of control vacuoles) |
stable efficiency (% of control PFU) |
---|---|---|---|
Tg Pc 4 (w.t.) | 7.4 ± 0.08 | 100 | 100 |
Tg T533A | 7.4 ± 0.18 | 105 ± 7.2 | 98 ± 6.9 |
Tg S581A | 7.3 ± 0.14 | 109 ± 11 | 104 ± 8.5 |
Tg Δ873-910 | 8.2 ± 0.27 | 113 ± 12 | 65 ± 11 |
Tg E1316A | nd | 0 | 0 |
Tg E1318A | nd | 0 | 0 |
Tg H1336K | nd | 0 | 0 |
Tg T1430A | 7.7 ± 0.21 | 86 ± 5.7 | 82 ± 8.4 |
Tg T1530A | 8.6 ± 0.25 | 51 ± 13 | 10 ± 3.2 |
Tg T1530 fs | nd | 0 | 0 |
Tg Δ1592-1628 | nd | 0 | 0 |
Tg T1649A | 8.5 ± 0.21 | 65 ± 5.2 | 37 ± 7.0 |
no growth rate detected (nd). Table 3 shows the effect of engineered mutations in the CPS domains of T. gondii CPSII on parasite growth rate, transient and stable complementation efficiency in cps1-1 complementation assays. See Table 2 for descriptions of complementation.